Filing Details

Accession Number:
0001181431-12-035283
Form Type:
4
Zero Holdings:
No
Publication Time:
2012-06-07 18:14:57
Reporting Period:
2012-06-06
Filing Date:
2012-06-07
Accepted Time:
2012-06-07 18:14:57
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
787253 Natural Alternatives International Inc NAII Medicinal Chemicals & Botanical Products (2833) 841007839
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1115556 A Mark Ledoux 1185 Linda Vista Dr
San Marcos CA 92078
Ceo/Chairman Yes Yes Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2012-06-06 10,000 $6.74 185,037 No 4 S Direct
Common Stock Disposition 2012-06-07 2,000 $0.00 183,037 No 4 G Direct
Common Stock Disposition 2012-06-06 20,000 $6.74 557,851 No 4 S Indirect By LeDoux Family Limited Partnership
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 G Direct
No 4 S Indirect By LeDoux Family Limited Partnership
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 41,416 Indirect By IRA
Common Stock 7,200 Indirect By Self as Custodian for Marcelle Jeannette LeDoux
Common Stock 800 Indirect By Self as Custodian for Jean-Marc Emile LeDoux
Common Stock 28,000 Indirect By 401(K)
Common Stock 36,677 Indirect By Self as Trustee for the LeDoux Family Trust U/D/T December 21, 1992
Footnotes
  1. This transaction represents a repurchase of common stock by the Company in a private transaction. The repurchase was approved by the Audit Committee and the independent members of the Company's Board of Directors on May 25, 2012.
  2. The approval of the Company's Audit Committee and Board of Directors was conditioned on a purchase price equal to 90% of the closing price of the Company's common stock as reported by Nasdaq on June 1, 2012, which date represented the third day after the filing by the Company of a Current Report on Form 8-K reporting the approval of the repurchase. The closing price on June 1, 2012 as reported by Nasdaq was $7.49.
  3. This transaction represents a donation of the shares to a private institution.